Lindbrook Capital, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$44,724
-50.4%
2,891
-49.7%
0.01%
-50.0%
Q2 2023$90,223
-26.8%
5,743
-23.2%
0.01%
-28.6%
Q1 2023$123,270
+73.9%
7,480
+64.6%
0.01%
+55.6%
Q4 2022$70,902
-17.6%
4,545
-31.7%
0.01%
-40.0%
Q3 2022$86,000
+1.2%
6,652
+10.4%
0.02%
+7.1%
Q2 2022$85,000
-18.3%
6,024
-16.8%
0.01%
-12.5%
Q1 2022$104,000
+44.4%
7,243
+37.6%
0.02%
+45.5%
Q4 2021$72,000
-21.7%
5,265
-6.7%
0.01%
-54.2%
Q3 2021$92,000
+2.2%
5,646
+5.7%
0.02%
+20.0%
Q2 2021$90,000
-29.7%
5,340
-23.9%
0.02%
-31.0%
Q1 2021$128,000
+9.4%
7,016
+9.1%
0.03%0.0%
Q4 2020$117,000
+12.5%
6,430
+10.0%
0.03%0.0%
Q3 2020$104,000
+4.0%
5,848
+4.5%
0.03%
-3.3%
Q2 2020$100,000
+53.8%
5,598
+31.3%
0.03%
+20.0%
Q1 2020$65,000
-34.3%
4,265
-15.2%
0.02%
-26.5%
Q4 2019$99,000
-1.0%
5,030
-13.4%
0.03%
-10.5%
Q3 2019$100,000
+66.7%
5,807
+69.3%
0.04%
+65.2%
Q2 2019$60,000
-61.3%
3,431
-55.0%
0.02%
-62.9%
Q1 2019$155,0007,6310.06%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders